“…The wide distribution is likely due to varying definition of pulmonary hypertension and entry criteria of study subjects. Pulmonary hypertension is more commonly seen with fibrotic lung disease, especially with severe pulmonary hypertension [1,2,6,7,8 ]. Recently, Shorr et al reported the prevalence of pulmonary hypertension in a large cohort of patients with sarcoidosis [9].…”
Pulmonary hypertension is not infrequently observed in sarcoidosis. Further studies are needed to elucidate the epidemiology, mechanisms, treatment, and significance of sarcoidosis-associated pulmonary hypertension.
“…The wide distribution is likely due to varying definition of pulmonary hypertension and entry criteria of study subjects. Pulmonary hypertension is more commonly seen with fibrotic lung disease, especially with severe pulmonary hypertension [1,2,6,7,8 ]. Recently, Shorr et al reported the prevalence of pulmonary hypertension in a large cohort of patients with sarcoidosis [9].…”
Pulmonary hypertension is not infrequently observed in sarcoidosis. Further studies are needed to elucidate the epidemiology, mechanisms, treatment, and significance of sarcoidosis-associated pulmonary hypertension.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.